From August 28, 2023 to September 30, 2023, the company has repurchased 140,646 shares, representing 0.19% for $0.12 million. With this, the company has completed the repurchase of 140,646 shares, representing 0.19% for $0.12 million under the buyback announced on August 30, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.479 USD | -8.76% | -15.98% | -76.52% |
May. 14 | Transcript : The Oncology Institute, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Earnings Flash (TOI) TOI MANAGEMENT LLC Reports Q1 Revenue $94.7M, vs. Street Est of $95.2M | MT |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-76.52% | 35.66M | |
+20.12% | 83.46B | |
-2.68% | 25.66B | |
+3.31% | 17.91B | |
-15.31% | 16.54B | |
+0.22% | 15.43B | |
+75.22% | 13.46B | |
+74.08% | 12.78B | |
+40.02% | 12.6B | |
+1.03% | 12.55B |
- Stock Market
- Equities
- TOI Stock
- News The Oncology Institute, Inc.
- Tranche Update on The Oncology Institute, Inc.'s Equity Buyback Plan announced on August 30, 2023.